ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Phreesia Life Sciences’ PatientInsights Named one of PM360’s 2021 Most Innovative Services

Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named PatientInsights, Phreesia Life Sciences’ market research platform, to its list of 2021 Most Innovative Services.

Over the last decade, PM360’s annual Innovations Issue has spotlighted the pharma industry’s most innovative companies, products, strategies, services and more. PatientInsights was one of 52 overall honorees, chosen from hundreds of submissions, and one of just eight services to be recognized for “compelling offerings that help the industry tackle new challenges.”

PM360 highlighted PatientInsights’ ability to reach patients with targeted custom surveys just before their doctors’ appointments, when they’re preparing to share their opinions and experiences about their health conditions or treatment. This process both ensures participants are real patients and produces more reliable data.

“We’re honored to receive this recognition for PatientInsights and the innovation it has brought to pharma market research,” Joyce Wang, Associate Research Director, Life Sciences, said. “By identifying ideal respondents based on their chart history, we’re thrilled to be able help our partners engage hard-to-reach patient groups and uncover key motivations, concerns and questions that drive patient health behaviors.”

On top of helping surveys reach clinically relevant audiences, PatientInsights’ electronic health record integrations enable the platform to bypass basic screening and demographic questions, PM360 noted. This winnowing process cuts surveys from the typical 30 to 40 questions down to about 15, resulting in more patient-friendly surveys that feature better, smarter questions and generate higher completion rates.

“At Phreesia Life Sciences, patient centricity is at the heart of everything we do,” David Linetsky, SVP of Life Sciences, said. “We’re very proud that PatientInsights not only helps companies conduct fast, actionable market research, but also lets patients quickly and easily share their opinions to help shape the future of their care. Every interaction with a patient is an opportunity to drive a positive outcome and to learn something that will help drive future outcomes.”

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect meaningfully with clinically relevant patients, delivering targeted health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful brand conversations, and our PatientInsights product enables our clients to better understand their target patient populations.

Phreesia meets patients where they are, both virtually and in-person, and reaches them at multiple touchpoints throughout their healthcare journey. To learn more about Phreesia Life Sciences, visit lifesciences.phreesia.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.